Advertisement

Recent Chemical Developments in the Field of Beta Adrenoceptor Blocking Drugs

Conference paper
  • 70 Downloads
Part of the Progress in Clinical Biochemistry and Medicine book series (PCBM, volume 3)

Abstract

ß-adrenoceptor blocking drugs have been recognized agents in the therapy of heart diseases and vascular hypertension for years. Since their discovery, they have had an unusual career in the heart and circulation sector. Initially, their administration was restricted to the treatment of angina pectoris. After an antihypertensive effect had been observed in patients with angina, they were also used in hypertension.

Keywords

Antihypertensive Effect Beta Adrenoceptor Hypotensive Effect Fixed Combination Antihypertensive Action 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shanks, R. G., in: Discoveries in Pharmacology, Vol. 2, p. 37 (M. J. Parnham, Bruinvels, eds.). Amsterdam: Elsevier 1984Google Scholar
  2. 2.
    Morganroth, J., in: The Evaluation of Beta Blocker and Calcium Antagonist Drugs, p. 2 (J. Morganroth, E. N. Moore, eds.). The Hague-Boston-London: Nijhoff 1982Google Scholar
  3. 2a.
    Abrams, W. B., in: The Evaluation of beta Blocker and Calcium Antagonist Drugs, p. 7 (J. Morganroth, E. N. Moore, eds.). The Hague-Boston-London: Nijhoff 1982Google Scholar
  4. 3.
    Lohmann, F. W. (ed.), in: Die klinische Bedeutung der ß 1-Selektivität, p. 9. München: Verlag für angewandte Wissenschaften 1984Google Scholar
  5. 4.
    Kewitz, H., in: ß-Rezeptorenblockade, p. 100 (F. W. Lohmann, ed.). Berlin-Heidelberg-New York: Springer 1982Google Scholar
  6. 5.
    Boite, H.-D. (ed.), in: Therapie mit Beta-Rezeptorenblockern, p. 19. Berlin-Heidelberg-New York: Springer 1979Google Scholar
  7. 6.
    Lüderitz, B., in: ß-Rezeptorenblockade, p. 76 (F. W. Lohmann, ed.). Berlin-Heidelberg-New York: Springer 1982Google Scholar
  8. 7.
    Prichard, B. N. C.: Brit. J. Clin. Pharmacol. 13, 51 (1982)Google Scholar
  9. 8.
    Prichard, B. N. C., in: Alpha and Beta Adrenoceptors and the Cardiovascular System, p. 178 (W. Kobinger, R. P. Ahlquist, eds.). Princeton: Excerpta Medica 1984Google Scholar
  10. 9.
    Simon, H.: Arzneim.-Forsch. 33, 277 (1983)Google Scholar
  11. 10.
    Lydtin, H., Lohmöller, G., in: Beta Blockers, p. 138. Bern-Stuttgart-Wien: Huber 1980Google Scholar
  12. 11.
    Lands, A. M., et al.: Nature 214, 597 (1967)PubMedGoogle Scholar
  13. 12.
    Dunlop, D., Shanks, R. G.: Brit. J. Pharmacol. 32, 201 (1968)PubMedGoogle Scholar
  14. 13.
    Åblad, B., et al., in: Die klinische Bedeutung der ß 1-Selektivität, p. 13 (Lohmann, F. W., ed.). München: Verlag für angewandte Wissenschaften 1984Google Scholar
  15. 14.
    Wolff, H. P., Schrey, A. (eds.), in: Beta-Blocker, Fragen und Antworten, Expertengespräch Triberg 1982, p. 4. München-Wien-Baltimore: Urban & Schwarzenberg 1984Google Scholar
  16. 15.
    Mutschier, E. (ed.), in: Arzneimittelwirkungen, p. 262. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH 1981Google Scholar
  17. 16.
    Gibson, D. G.: Drugs 7, 8 (1974)PubMedGoogle Scholar
  18. 17.
    Schier, O., et al.: Progr. Drug Res. 25, 9 (1981)Google Scholar
  19. 18.
    Evans, D. B., et al.: Ann. Rep. Med. Chem. 14, 81 (1979)Google Scholar
  20. 19.
    Ahlquist, R. P.: Progr. Drug Res. 20, 27 (1976)Google Scholar
  21. 20.
    Weetman, D. F.: Drugs Today 13, 261 (1977)Google Scholar
  22. 21.
    Kobinger, W., Ahlquist, R. P. (eds): Alpha and Beta Adrenoceptors and the Cardiovascular System. Princeton: Excerpta Medica 1984Google Scholar
  23. 22.
    Borchard, U. (ed.): Pharmakologie der ß-Rezeptorenblocker. Basel: Aesopus 1983Google Scholar
  24. 23.
    Ahlquist, R. P.: Am. J. Physiol. 153, 586 (1948)PubMedGoogle Scholar
  25. 24.
    Shanks, R. G., in: Discoveries in Pharmacology, Vol. 2, p. 41 (M. J. Parnham, J. Bruinvels, eds.). Amsterdam: Elsevier 1984Google Scholar
  26. 25.
    Mills, J.: US 2938921 (1960)Google Scholar
  27. 26.
    Powell, C. E. Slater, I. H.: J. Pharmacol. Exp. Ther. 122, 470 (1958)Google Scholar
  28. 27.
    Moran, H. C., Perkins, M. E.: J. Pharmacol. Exp. Ther. 124, 223 (1958)PubMedGoogle Scholar
  29. 28.
    Shanks, R. G., in: Discoveries in Pharmacology, Vol. 2, p. 68 (M. J. Parnham, J. Bruinvels, eds.). Amsterdam: Elsevier 1984Google Scholar
  30. 29.
    Scheuing, G., Thomä, O.: DRP 723278 (1939)Google Scholar
  31. 30.
    Köppe, H.: Postgrad. Med. J. Suppl. (1) 53, 22 (1977)Google Scholar
  32. 31.
    Engelhardt, A.: Unpubl. results 1961Google Scholar
  33. 32.
    Köppe, H., et al.: Belg. P. 652, 336 (1964)Google Scholar
  34. 33.
    Engelhardt, A.: Naunyn Schmiedeberg’s Arch. exp. Pathol. Pharmacol. 250, 245 (1965)Google Scholar
  35. 34.
    Shanks, R. G., et al.: Nature 212, 88 (1966)PubMedGoogle Scholar
  36. 35.
    Nayler, W. G., et al.: J. Pharmacol. Exp. Ther. 165, 22 (1969)Google Scholar
  37. 36.
    Somani, P., et al.: Eur. J. Pharmacol. 14, 209 (1971)PubMedGoogle Scholar
  38. 37.
    Wirtzfeld, A., et al.: Z. Kardiol. 71, 619 (1982)Google Scholar
  39. 38.
    Köppe, H., et al.: JP 796550 (1964)Google Scholar
  40. 39.
    Engelhardt, A.: Unpublished results 1963Google Scholar
  41. 40.
    Carlsson, E., et al.: Arch. Pharmacol. 300, 101 (1977)Google Scholar
  42. 41.
    Dahlstrom, V., et al.: Eur. J. Clin. Pharmacol. 24, 495 (1983)PubMedGoogle Scholar
  43. 42.
    Graffner, C., et al.: Eur. J. Pharmacol. 20, 91 (1981)Google Scholar
  44. 43.
    Ostermayer, F., et al.: EP 15505 (1980)Google Scholar
  45. 44.
    Ostermayer, F., et al.: EP 45964 (1982)Google Scholar
  46. 45.
    Fuhrer, W., et al.: J. Med. Chem. 27, 831 (1984)PubMedGoogle Scholar
  47. 46.
    Carlsson, E., et al.: EP 64487 (1982)Google Scholar
  48. 47.
    Barlow, J. J., et al.: J. Med. Chem. 23, 624 (1980)Google Scholar
  49. 48.
    Drugs in the Future 7, 571 (1982); 8, 736 (1983)Google Scholar
  50. 49.
    Barlow, J. J., et al.: J. Med. Chem. 24, 315 (1981)PubMedGoogle Scholar
  51. 50.
    Louis, W. J.: EP 105838 (1984)Google Scholar
  52. 51.
    Poittevin, A., et al.: DOS 2514630 (1975)Google Scholar
  53. 52.
    Lövgren, K., et al.: J. Med. Chem. 23, 624 (1980)PubMedGoogle Scholar
  54. 53.
    Dunlop, D., Shanks, R. G.: Brit. J. Pharmacol. 32, 201 (1968)PubMedGoogle Scholar
  55. 54.
    Lands, A. M., et al.: Nature 214, 597 (1967)PubMedGoogle Scholar
  56. 55.
    Carlsson, E., et al.: Life Sci. II Part 1, 953 (1972)Google Scholar
  57. 56.
    Waal Manning, H. J., et al.: Lancet, 1971-II 1264Google Scholar
  58. 57.
    Mutschier, E.: Dtsch. Apothekerz. 123, 1723 (1983)Google Scholar
  59. 58.
    Smith, U., in: Die klinische Bedeutung der ß 1-Selektivität, p. 55 (Lohmann, F. W., ed.). München: Verlag für angewandte Wissenschaften 1984Google Scholar
  60. 59.
    Holm, G. S., et al.: Acta Med. Scand. 208, 187 (1980)PubMedGoogle Scholar
  61. 60.
    Howe, R., et al.: DOS 1643425 (1968)Google Scholar
  62. 61.
    Smith, L. H.: DOS 1936693 (1970)Google Scholar
  63. 62.
    Crowther, et al.: J. Med. Chem. 14, 511 (1971)PubMedGoogle Scholar
  64. 63.
    Lydtin, H., in: Beta Blockers, p. 149 (Lydtin, H., Lohmöller, G., eds.). Bern-Stuttgart-Wien: Huber 1980Google Scholar
  65. 64.
    Barrett, A. M., et al.: DE 2007751 (1971)Google Scholar
  66. 65.
    Graham, B. R., et al.: Brit. J. Pharmacol. 49, 154 (1973)Google Scholar
  67. 66.
    Marmo, E.: Drugs exp. clin. Res. 6, 639 (1980)Google Scholar
  68. 67.
    Brunner, H., et al.: Klin. Wschr. 56, Suppl. 1, 107 (1978)PubMedGoogle Scholar
  69. 68.
    Isbary, J., et al.: Z. Kardiol. 67, 857 (1978)PubMedGoogle Scholar
  70. 69.
    Myers, M. G., et al.: Clin. Pharmacol. Ther. 27, 756 (1980)PubMedGoogle Scholar
  71. 70.
    Wooldridge, K., et al.: DOS 1815808 (1970)Google Scholar
  72. 71.
    Basil, B., et al.: J. Med. Chem. 19, 399 (1976)PubMedGoogle Scholar
  73. 72.
    Watson, R. D. S., et al.: Brit. J. Pharmacol. 7, 557 (1979)Google Scholar
  74. 73.
    Main, B. G.: J. Chem. Techn. Biotechnol. 32, 617 (1982)Google Scholar
  75. 74.
    Holmes, A., et al.: DOS 2259489 (1971)Google Scholar
  76. 75.
    Hoefle, M. L., et al.: J. Med. Chem. 18, 148 (1975)PubMedGoogle Scholar
  77. 76.
    Gross, G. J., et al.: J. Cardiovasc. Pharmacol. 1, 139 (1979)PubMedGoogle Scholar
  78. 77.
    Augstein, J., et al.: DOS 1957706 (1970)Google Scholar
  79. 78.
    Augstein, J., et al.: J. Med. Chem. 16, 1245 (1973)PubMedGoogle Scholar
  80. 79.
    Pfisterer, M., et al.: Schweiz. Med. Wschr. 106, 549 (1976)PubMedGoogle Scholar
  81. 80.
    Rzeszotarski, W. J., et al.: J. Med. Chem. 26, 644 (1983)PubMedGoogle Scholar
  82. 81.
    Rzeszotarski, W. J., et al.: J. Med. Chem. 22, 735 (1979)PubMedGoogle Scholar
  83. 82.
    Cohnen, E.: DE 3030530 (1982)Google Scholar
  84. 83.
    Cohnen, E.: DE 3030573 (1982)Google Scholar
  85. 84.
    Bercher, H., et al.: DD 153682 (1982)Google Scholar
  86. 85.
    Zoelss, G.: DOS 2458624 (1974)Google Scholar
  87. 86.
    Zoelss, G.: Arzneim.-Forsch. Drug Res. 33, 2 (1983)Google Scholar
  88. 87.
    Köppe, H., et al.: DAS 1593782 (1972)Google Scholar
  89. 88.
    Köppe, H., et al.: DAS 1643262 (1972)Google Scholar
  90. 89.
    Köppe, H., et al.: DOS 2309887 (1974)Google Scholar
  91. 90.
    Köppe, H., et al.: DAS 1543391 (1972)Google Scholar
  92. 91.
    Muacevic, G., Traunecker, W.: Publication in progressGoogle Scholar
  93. 91a.
    Mylecharane, E. J., et al.: Eur. J. Pharmacol. 21, 375 (1973)PubMedGoogle Scholar
  94. 92.
    Köppe, H., et al.: EP 101498 (1981)Google Scholar
  95. 93.
    Köppe, H., et al.: EP 101499 (1981)Google Scholar
  96. 94.
    Köppe, H., et al.: EP 102294 (1981)Google Scholar
  97. 95.
    Köppe, H., et al.: EP 107519 (1982)Google Scholar
  98. 96.
    Köppe, H., et al.: EP 107536 (1982)Google Scholar
  99. 97.
    Traunecker, W.: Arzneim.-Forsch. Drug Res. 35 (I) la, 376 (1985)Google Scholar
  100. 98.
    Brogden, R. C., et al.: Drugs 14, 321 (1977)PubMedGoogle Scholar
  101. 99.
    Clausen, N., et al.: Brit. J. Clin. Pharmacol. 7, 379 (1979)Google Scholar
  102. 100.
    Cohnen, E., et al.: DE 3151201 (1983)Google Scholar
  103. 101.
    Manoury, P. M., et al.: DOS 2649605 (1980)Google Scholar
  104. 102.
    Bianchetti, G., et al.: Arzneim.-Forsch. 30, 1912 (1980)Google Scholar
  105. 103.
    Balnave, K., et al.: Brit. J. Clin. Pharmacol. 11, 171 (1981)Google Scholar
  106. 104.
    Assael, B. M., et al.: Clin. Pharmacol. Ther. 29, 232 (1981)Google Scholar
  107. 105.
    Pouleur, H., et al.: J. Cardiovasc. Pharmacol. 6, 720 (1984)PubMedGoogle Scholar
  108. 106.
    Regnier, F., et al.: Therapie 38, 155 (1983)PubMedGoogle Scholar
  109. 107.
    Berthold, R., et al.: EP 52072 (1982)Google Scholar
  110. 108.
    Gustafsson, et al.: EP 85286 (1983)Google Scholar
  111. 109.
    Machin, P. J., et al.: EP 41233 (1981)Google Scholar
  112. 110.
    Machin, P. J., et al.: J. Med. Chem. 26, 1570 (1983)PubMedGoogle Scholar
  113. 111.
    Manoury, P., et al.: EP 61379 (1982)Google Scholar
  114. 112.
    Muro, T., et al.: WO 8401945 (1984)Google Scholar
  115. 113.
    Machin, P. J.: EP 34831 (1981)Google Scholar
  116. 114.
    Machin, P. J., et al.: J. Med. Chem. 27, 503 (1984)PubMedGoogle Scholar
  117. 115.
    Lindner, E.: Arzneim.-Forsch. 34, 270 (1984)Google Scholar
  118. 116.
    Fritsch, W., et al.: DE 2623314 (1977)Google Scholar
  119. 117.
    Witte, P. U., et al.: Naunyn Schmiedeberg’s Arch. Pharmacol. 322 (Suppl.) Abst. 522 (1983)Google Scholar
  120. 118.
    Tominaga, M., et al.: DOS 2711719 (1977)Google Scholar
  121. 119.
    Tominaga, M.: Chem. Pharm. Bull. 29, 2166 (1981)PubMedGoogle Scholar
  122. 120.
    Sugawara, K., et al.: Arch. int. Pharmacodyn. 240, 294 (1979)PubMedGoogle Scholar
  123. 121.
    Yo, E., et al.: Chem. Pharm. Bull. 29, 2157 (1981)PubMedGoogle Scholar
  124. 122.
    Baldwin, J. J., et al.: J. Med. Chem. 26, 950 (1983)PubMedGoogle Scholar
  125. 123.
    Baldwin, J. J., et al.: VIIIth Int. Symp. Med. Chem. Uppsala, Abstracts 11 (1984)Google Scholar
  126. 124.
    Ostermayer, F., et al.: EP 45964 (1982)Google Scholar
  127. 125.
    Fuhrer, W., et al.: DE 3314196 (1983)Google Scholar
  128. 126.
    Jaeggi, K. A., et al.: GB 2014146 (1979)Google Scholar
  129. 127.
    Lehmann, D., et al.: DE 2844497 (1978)Google Scholar
  130. 128.
    Casagrande, C., et al.: EP 116825 (1984)Google Scholar
  131. 129.
    Mennini, T., et al.: J. Mol. Cell. Cardiol. 16, Suppl. (1984)Google Scholar
  132. 130.
    Nicola, M., et al.: VIIIth Int. Symp. Med. Chem. Uppsala, Abstracts 23 (1984)Google Scholar
  133. 131.
    Smith, L. H.: DE 2362568 (1974)Google Scholar
  134. 132.
    Smith, L. H.: DE 2525133 (1975)Google Scholar
  135. 133.
    Smith, H. J., et al.: J. Pharm. Exp. Ther. 226, 211 (1983)Google Scholar
  136. 134.
    Norris, S. C., et al.: Brit. J. Clin. Pharmacol. 18, 271 (1984)Google Scholar
  137. 135.
    Harry, J. D., et al.: Brit. J. Clin. Pharmacol. 18, 291 (1984)Google Scholar
  138. 136.
    Large, M. S., et al.: J. Med. Chem. 25, 1286 (1982)Google Scholar
  139. 137.
    Majid, P. A., et al.: J. Cardiovasc. Pharmacol. 2, 435 (1980)PubMedGoogle Scholar
  140. 138.
    Matier, W. L., et al.: DE 3217206 (1982)Google Scholar
  141. 139.
    Raabe, T., et al.: DE 3048487 (1982)Google Scholar
  142. 140.
    Raabe, T., et al.: DOS 2819629 (1978)Google Scholar
  143. 141.
    Suntory Ltd. J 59164786 (1984)Google Scholar
  144. 142.
    Howe, R., Shanks, R. G.: Nature 210, 1336 (1966)PubMedGoogle Scholar
  145. 143.
    Schmitt, K., et al.: DOS 1668055 (1971)Google Scholar
  146. 144.
    Härtfelder, G., et al.: Arzneim.-Forsch. 22, 930 (1972)Google Scholar
  147. 145.
    Vierhapper, H., et al.: Arzneim.-Forsch. 30, 1008 (1980)Google Scholar
  148. 146.
    von Leitner, E. R., et al.: Eur. J. Cardiol. 12, 121 (1980)Google Scholar
  149. 147.
    Shavel, J., et al.: DOS 1948144 (1969)Google Scholar
  150. 148.
    Shavel, J., et al.: DOS 2046043 (1971)Google Scholar
  151. 149.
    Schwender, C. F., et al.: J. Med. Chem. 13, 684 (1970)PubMedGoogle Scholar
  152. 150.
    Commarato, M. A., et al.: Arch. Int. Pharmacodyn. Ther. 226, 205 (1977)PubMedGoogle Scholar
  153. 151.
    Duzman, E., et al.: Am. J. Ophthalmol. 94, 318 (1982)PubMedGoogle Scholar
  154. 152.
    Quast, U., et al.: Arzneim.-Forsch. 34, 579 (1984)Google Scholar
  155. 153.
    Bartsch, W.: DE 3300933 (1984)Google Scholar
  156. 154.
    Leinert, H.: DE 3319027 (1984)Google Scholar
  157. 155.
    Innis, R. B., et al.: Life Sci. 24, 2255 (1979)PubMedGoogle Scholar
  158. 156.
    Bartsch, W., et al.: Arzneim.-Forsch. 27, 1022 (1977)Google Scholar
  159. 157.
    Ghirardi, P., et al.: Cardiovasc. Pharmacol. 2, 471 (1980)Google Scholar
  160. 158.
    Grosso, F., et al.: Acta Ther. 6, 87 (1980)Google Scholar
  161. 159.
    Nicaise, P., et al.: Curr. Ther. Res. 30, 93 (1981)Google Scholar
  162. 160.
    Ehrhardt, P. W., et al.: J. Med. Chem. 25, 1402 (1982)Google Scholar
  163. 161.
    Badia, A.: Drugs of the Future 9, 183 (1984)Google Scholar
  164. 162.
    Sakanashi, M.: Trends Pharmacol. Sci. 234 (1981)Google Scholar
  165. 163.
    Maseri, A., et al: N. Engl. J. Med. 299, 1271 (1978)PubMedGoogle Scholar
  166. 164.
    Kam, S., et al.: J. Med. Chem. 27, 1007 (1984)PubMedGoogle Scholar
  167. 165.
    Zaroslinski, J., et al.: Life Sci. 31, 899 (1982)PubMedGoogle Scholar
  168. 166.
    Ehrhardt, P. W., et al.: US 4450173 (1982)Google Scholar
  169. 167.
    Ehrhardt, P. W., et al.: EP 53435 (1982)Google Scholar
  170. 168.
    Matier, W. L.: WO 83/00043 (1981)Google Scholar
  171. 169.
    Kam, S., et al.: WO 83/01868 (1981)Google Scholar
  172. 170.
    Jacobi, A., et al.: J. Pharm. Sci. 72, 710 (1983)Google Scholar
  173. 171.
    Ehrhardt, P. W., et al.: J. Med. Chem. 26, 1109 (1983)Google Scholar
  174. 172.
    Black, J. W.: J. Pharm. Pharmacol. 12, 87 (1960)PubMedGoogle Scholar
  175. 173.
    Prichard, B. N. C.: Brit. Med. J. 1, 1227 (1964)PubMedGoogle Scholar
  176. 174.
    Prichard, B. N., et al.: Brit. Med. J. 2, 725 (1964)PubMedGoogle Scholar
  177. 175.
    Hansson, L., in: ß-Rezeptorenblockade, p. 78 (Lohmann, F. W., ed.). Berlin-Heidelberg-New York: Springer 1982Google Scholar
  178. 176.
    Prichard, B. N. C., et al.: Cardiology 66 (Suppl.), 1 (1980)PubMedGoogle Scholar
  179. 177.
    Wolff, H. P., in: Beta-Blocker, Fragen und Antworten, p. 22 (Wolff, H. P., Schrey, A., eds.). München-Wien-Baltimore: Urban & Schwarzenberg 1984Google Scholar
  180. 178.
    Gross, F.: Inn. Med. 9, All (1982)Google Scholar
  181. 179.
    Mutschier, E.: Arzneimittelwirkungen, p. 262. Stuttgart: Wiss. Verlagsgesellschaft 1981Google Scholar
  182. 180.
    Diamond, J.: US 4434174 (1982), EP 34116 (1981)Google Scholar
  183. 181.
    Köppe, H., et al.: DOS 2644833 (1976)Google Scholar
  184. 182.
    Hoefke, W., et al.: Naunyn Schmiedeberg’s Arch. Pharmacol. 325, 54 (1984)Google Scholar
  185. 183.
    Wiedemann, L: Arzneim.-Forsch. 33, 861 (1983)Google Scholar
  186. 184.
    Palluk, R., et al.: Naunyn Schmiedeberg’s Arch. Pharmacol. 329, R 79, Abst. 314 (1985)Google Scholar
  187. 185.
    Werner, L. H., et al.: EP 96006 (1983)Google Scholar
  188. 186.
    Hamilton, R. W., et al.: DE 3122814 (1982)Google Scholar
  189. 187.
    Obase, H., et al.: Chem. Pharm. Bull. 30, 474 (1982)PubMedGoogle Scholar
  190. 188.
    Clark, R. D., et al.: J. Med. Chem. 26, 657 (1983)PubMedGoogle Scholar
  191. 189.
    Lunts, L. H., et al.: DOS 2616403 (1978)Google Scholar
  192. 190.
    Farmer, J. B., et al.: Brit. J. Pharmac. 45, 660 (1972)Google Scholar
  193. 191.
    Richards, D. A., et al.: Brit. J. Clin. Pharm. 3, 967 (1976)Google Scholar
  194. 192.
    Sybertz, E. J., et al.: J. Pharmacol. Exp. Ther. 218, 435 (1981)PubMedGoogle Scholar
  195. 193.
    Borchard, U.: Selecta 52, 4313 (1984)Google Scholar
  196. 194.
    Brogden, R. N., et al.: Drugs 15, 251 (1978)PubMedGoogle Scholar
  197. 195.
    Lund-Johansen, P., et al.: Brit. J. Clin. Pharmacol. 7, 169 (1979)Google Scholar
  198. 196.
    Vlackakis, N. D., et al.: Pharmacology 22 (3), Abstract 176 (1980)Google Scholar
  199. 197.
    Schechter, P. J., et al.: J. Cardiovasc. Pharmacol. 5, 143 (1983)Google Scholar
  200. 198.
    Cheng, H. C., et al.: Pharmacology 22 (3), Abstract 31 (1980)Google Scholar
  201. 199.
    Kubo, K., et al.: Arzneim.-Forsch. 33, 926 (1983)Google Scholar
  202. 200.
    Takizawa, H., et al.: DE 3010752 (1980)Google Scholar
  203. 201.
    Berthold, R.: CH 634050 (1983)Google Scholar
  204. 202.
    Bhattacharjee, et al.: Brit. J. Pharmacol. 80, 491 (1983) (Proc. Suppl.)Google Scholar
  205. 203.
    Berthold, R.: DE 3200304 (1982)Google Scholar
  206. 204.
    Takahashi, T., et al.: EP 113910 (1984)Google Scholar
  207. 205.
    Gross, F.: Inn. Med. 9, 429 (1982)Google Scholar
  208. 206.
    Barlow, J. J., et al.: EP 86564 (1983)Google Scholar
  209. 207.
    Barlow, J. J., et al.: EP 57572 (1982)Google Scholar
  210. 208.
    Atkinson, J. G., et al.: US 4442094 (1984)Google Scholar
  211. 209.
    Payne, T. G., et al.: DOS 2810869 (1978)Google Scholar
  212. 210.
    Berthold, R., et al.: DOS 2802758 (1979)Google Scholar
  213. 211.
    Bouley, E., et al.: EP 99822 (1984)Google Scholar
  214. 212.
    Bouley, E., et al.: EP 122827 (1984)Google Scholar
  215. 213.
    Gross, F.: Brit. J. Clin. Pharmacol. 13, 133 (1982)Google Scholar
  216. 214.
    Köppe, H.: Plenary lecture, 56th Chemical Conference and Exhibition, Med. Chem. Div., Montreal 1973Google Scholar
  217. 215.
    Traunecker, W., Häselbarth, V., Brückner, S., in: Pharmacology of Antihypertensive Drugs, p. 307 (A. Scriabine, ed.). New York: Raven Press 1980Google Scholar
  218. 216.
    Kreighbaum, W. E., et al.: DOS 2830884 (1979)Google Scholar
  219. 217.
    Kreighbaum, W. E., et al.: J. Med. Chem. 23, 285 (1980)PubMedGoogle Scholar
  220. 218.
    Deitchman, D., et al.: Arch. Int. Pharmacodyn. 247, 76 (1980)PubMedGoogle Scholar
  221. 219.
    Deitchman, D., et al.: Eur. J. Pharmacol. 61, 263 (1980)PubMedGoogle Scholar
  222. 220.
    Oates, H. F., et al.: Arch. Int. Pharmacodyn. Ther. 251, 95 (1981)PubMedGoogle Scholar
  223. 221.
    Dolak, T. M., et al.: VlIIth Int. Symp. Med. Chem. Uppsala 1984, Abstracts 17Google Scholar
  224. 222.
    Baldwin, J. J.: DOS 2556110 (1976)Google Scholar
  225. 223.
    Baldwin, J. J.: DOS 2726754 (1978)Google Scholar
  226. 224.
    Sweet, C. S., et al.: J. Pharmacol. Exp. Ther. 211, 195 (1979)PubMedGoogle Scholar
  227. 225.
    Sweet, C. S., et al.: J. Pharmacol. Exp. Ther. 211, 200 (1978)Google Scholar
  228. 226.
    Scriabine, A., et al.: Experientia 35, 1634 (1979)PubMedGoogle Scholar
  229. 227.
    Baldwin, J. J., et al.: J. Med. Chem. 22, 1284 (1979)PubMedGoogle Scholar
  230. 228.
    Kreighbaum, W.: DE 3331612 (1984)Google Scholar
  231. 228a.
    Knoll, J., et al.: DE 3301198 (1984)Google Scholar
  232. 229.
    Troxler, F., et al.: DOS 1620342 (1966)Google Scholar
  233. 230.
    Saameli, K.: Helv. Physiol. Acta 25, 219 (1967)Google Scholar
  234. 231.
    Hill, R. C., et al.: Brit. J. Pharmacol. 36, 368 (1969)Google Scholar
  235. 232.
    Wolff, H. P.: Dtsch. Med. Wschr. 100, 1726 (1975)PubMedGoogle Scholar
  236. 233.
    Kampe, W., et al.: DOS 2651574 (1978), DOS 2737630 (1979), Circul. 45, 571 (1972)Google Scholar
  237. 234.
    v. Möllendorff, E., et al.: Clin. Sci. 61, All (1981)Google Scholar
  238. 235.
    v. Möllendorff, E., et al.: Münch. Med. Wschr. 123 164 (1981)Google Scholar
  239. 236.
    Wiedemann, F., et al.: DOS 2815926 (1979)Google Scholar
  240. 237.
    Sponer, G., et al.: Naunyn Schmiedeberg’s Arch. Pharmacol. 32 (Suppl.), Abstr. 81 (1982).Google Scholar
  241. 238.
    Strein, K., et al.: Naunyn Schmiedeberg’s Arch. Pharmacol. 325 (Suppl.), Abstr. 207 (1984)Google Scholar
  242. 239.
    Shiratsuchi, M., et al.: VlIIth Int. Symp. Med. Chem. Uppsala, Abstr. 25 (1984)Google Scholar
  243. 240.
    Shiratsuchi, M., et al.: EP 83256 (1983)Google Scholar
  244. 241.
    Shiratsuchi, M., et al.: EP 105763 (1984)Google Scholar
  245. 242.
    Shiratsuchi, M., et al.: EP 42299 (1981)Google Scholar
  246. 243.
    Shimitsu, S., et al.: Jap. J. Pharmacol. 32 (Suppl.), 135 (1982)Google Scholar
  247. 244.
    Asada, H., et al.: J. Pharmacol. Exp. Ther. 223, 560 (1982)PubMedGoogle Scholar
  248. 245.
    Shirasawa, Y., et al.: Jap. J. Pharmacol. 32 (Suppl.), 175 (1982)Google Scholar
  249. 246.
    Druey, A., et al.: Helv. 34, 195 (1951)Google Scholar
  250. 246a.
    Druey, A., et al. Angew. Chem. 70, 5 (1958)Google Scholar
  251. 247.
    Gross, F., et al.: Experientia 6, 19 (1950)PubMedGoogle Scholar
  252. 248.
    Carpi, C., et al.: US 4002753 (1976)Google Scholar
  253. 249.
    Roe, A. M., et al.: DOS 2705414 (1977)Google Scholar
  254. 250.
    Dorigotti, L., et al.: EP 18016 (1980)Google Scholar
  255. 251.
    Coates, W. J., et al.: Brit. P 1548601 (1979)Google Scholar
  256. 252.
    Coates, W. J., et al.: DOS 2527066 (1976)Google Scholar
  257. 253.
    Larsson, R., et al.: Clin. Pharmacol. Ther. 29, 588 (1981)PubMedGoogle Scholar
  258. 254.
    Luscher, T., et al.: Eur. J. Clin. Pharmacol. 23, 411 (1982)PubMedGoogle Scholar
  259. 255.
    Lund-Johansen, P., et al.: J. Cardiovasc. Pharmacol. 4, 1012 (1982)PubMedGoogle Scholar
  260. 256.
    Jasuda, K., et al.: EP 97202 (1984)Google Scholar
  261. 257.
    Briggs, M. T., et al.: EP 92945 (1983)Google Scholar
  262. 258.
    Teikoku Hormone Ltd.: JP 56142272 (1981); JP 56169675 (1981)Google Scholar
  263. 259.
    Phillips, C.I., et al.: Brit. J. Ophthalmol. 51, 222 (1967)Google Scholar
  264. 260.
    Bietti, G. B., et al.: Klin. Mbl. Augenheilk. 170, 824 (1977)PubMedGoogle Scholar
  265. 261.
    Zimmerman, T. J., et al.: Arch. Ophthalmol. 95, 601 (1977)PubMedGoogle Scholar
  266. 262.
    Atkinson, J. G., et al.: US 4349673 (1982)Google Scholar
  267. 263.
    Harting, J.: EP 68160 (1982)Google Scholar
  268. 264.
    Tattensfield, A. E.: Brit. J. Pharmacol. 27, 135 (1984)Google Scholar
  269. 265.
    Prager, G., et al.: Dtsch. Med. Wschr. 109, 1914 (1984)PubMedGoogle Scholar
  270. 266.
    Wasson, B. K., et al.: J. Med. Chem. 15, 651 (1972).PubMedGoogle Scholar
  271. 267.
    Heel, R. C., et al.: Drugs 17, 38 (1979)PubMedGoogle Scholar
  272. 268.
    Matier, W. L., et al.: WO 8402525 (1984)Google Scholar
  273. 269.
    Baldwin, J. J., et al.: US 4472427 (1984)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  1. 1.Department of Medicinal ChemistryBoehringer Ingelheim KGIngelheim am RheinWest Germany

Personalised recommendations